Daily Stock Analysis, AXGN, AxoGen Inc, priceseries

AxoGen Inc. Daily Stock Analysis
Stock Information
Open
38.95
Close
38.70
High
39.15
Low
38.30
Previous Close
38.70
Daily Price Gain
0.00
YTD High
41.73
YTD High Date
Apr 20, 2018
YTD Low
23.60
YTD Low Date
Feb 9, 2018
YTD Price Change
10.75
YTD Gain
38.46%
52 Week High
41.73
52 Week High Date
Apr 20, 2018
52 Week Low
11.45
52 Week Low Date
Apr 25, 2017
52 Week Price Change
27.00
52 Week Gain
230.77%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Jan 6. 2017
9.30
Jan 19. 2017
9.91
8 Trading Days
6.51%
Link
LONG
Apr 11. 2017
10.90
May 4. 2017
11.89
16 Trading Days
9.06%
Link
LONG
May 12. 2017
13.15
Jun 12. 2017
14.89
20 Trading Days
13.27%
Link
LONG
Jun 28. 2017
15.25
Jul 13. 2017
16.12
10 Trading Days
5.69%
Link
LONG
Aug 22. 2017
15.70
Oct 3. 2017
18.67
29 Trading Days
18.94%
Link
LONG
Oct 30. 2017
20.15
Nov 16. 2017
22.25
13 Trading Days
10.42%
Link
LONG
Nov 20. 2017
24.30
Jan 9. 2018
28.30
33 Trading Days
16.45%
Link
LONG
Feb 13. 2018
26.25
Mar 28. 2018
37.87
30 Trading Days
44.26%
Link
Company Information
Stock Symbol
AXGN
Exchange
NasdaqCM
Company URL
http://www.axogeninc.com
Company Phone
(386) 462-6817
CEO
Karen L. Zaderej
Headquarters
Florida
Business Address
13631 PROGRESS BLVD., SUITE 400, ALACHUA, FL 32615
Sector
Equity
Industry Category
Health Services
Industry Group
Medical Appliances & Equipment
CIK
0000805928
About

AxoGen, Inc. is a regenerative medicine company, which is focused on the science, development and commercialization of technologies for peripheral nerve solutions. Its products include Avance Nerve Graft, AxoGuard Nerve Protector and AxoGuard Nerve Connector. The company was founded in 1977 and is headquartered in Alachua, FL.

Description

AxoGen, Inc. provides surgical solutions for peripheral nerve injuries. The company's surgical nerve repair solutions include Avance Nerve Graft, an off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed nerves; and AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect injured peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments. Its solutions also comprise Avive Soft Tissue Membrane, a minimally processed human umbilical cord membrane that is used as a resorbable soft tissue covering to separate tissues and modulate inflammation in the surgical bed. In addition, the company offers AcroVal neurosensory and motor testing system, which consists of AcroGrip for use in hand grip strength measurement; AcroPinch for measuring pinch strength; and Pressure-Specified Sensory Device, a somatosensory evaluation and measurement device. Further, it provides AxoTouch two point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. The company provides its products to hospitals, surgery centers, and military hospitals in the United States, Canada, the United Kingdom and other European countries, and internationally. AxoGen, Inc. is headquartered in Alachua, Florida.